{"nct_id":"NCT06717347","title":"A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-01-27","start_date_type":"ACTUAL","primary_completion_date":"2029-07-02","primary_completion_date_type":"ESTIMATED","completion_date":"2032-03-29","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}